Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.14343/JCSCR.2014.2E1006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Depletion of the Aryl Hydrocarbon Receptor in MDA-MB-231 Human Breast Cancer Cells Altered the Expression of Genes in Key Regulatory Pathways of Cancer

  2014cited by this paper
• Neutrophil gelatinase-associated lipocalin in cancer.

  2014cited by this paper
• Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden

  2014cited by this paper
• Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

  2014cited by this paper
• Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.

  2014cited by this paper
• Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden

  2013cited by this paper
• Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research

  2013cited by this paper
• Morbid obesity resulting from inactivation of the ciliary protein CEP19 in humans and mice.

  2013cited by this paper
• Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research

  2013cited by this paper
• Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis

  2013cited by this paper
• Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance

  2013cited by this paper
• MAL2 expression predicts distant metastasis and short survival in pancreatic cancer.

  2013cited by this paper
• Claudin-1 as a promoter of EMT in hepatocellular carcinoma

  2013cited by this paper
• LRG1 promotes angiogenesis by modulating endothelial TGFß signalling

  2013cited by this paper
• Polo-like kinase 1 as target for cancer therapy

  2012cited by this paper
• CD133 expression associated with poor prognosis in ovarian cancer

  2012cited by this paper
• Membrane transporters as determinants of the pharmacology of platinum anticancer drugs.

  2012cited by this paper
• Proteomic characterization of ovarian cancers identifying annexin‐A4, phosphoserine aminotransferase, cellular retinoic acid‐binding protein 2, and serpin B5 as histology‐specific biomarkers

  2012cited by this paper
• Serine protease inhibitor A3 in atherosclerosis and aneurysm disease.

  2012cited by this paper
• Molecular mechanisms of cisplatin resistance

  2012cited by this paper
• Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes

  2012cited by this paper
• RGS2 is a component of the cellular stress response.

  2012cited by this paper
• Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer

  2012cited by this paper
• Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.

  2012cited by this paper
• Angiogenesis: a promising therapeutic target for ovarian cancer.

  2012cited by this paper
• Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice.

  2012cited by this paper
• Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.

  2012cited by this paper
• Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

  2012cited by this paper
• Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed by novel inhibitory human TLR4 mAbs.

  2012cited by this paper
• Genistein‐induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study

  2012cited by this paper
• Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors

  2012influential reference
• Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel

  2012cited by this paper
• Bcl11a is essential for lymphoid development and negatively regulates p53

  2012cited by this paper
• The Actin Regulatory Protein HS1 Interacts with Arp2/3 and Mediates Efficient Neutrophil Chemotaxis*

  2012cited by this paper
• Polymerized Laminin-332 Matrix Supports Rapid and Tight Adhesion of Keratinocytes, Suppressing Cell Migration

  2012cited by this paper
• The lymphangiogenic factor SOX 18: A key indicator to stage gastric tumor progression

  2012cited by this paper
• Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2

  2011cited by this paper
• Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer.

  2011cited by this paper
• Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides

  2011cited by this paper
• A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer.

  2011cited by this paper
• Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

  2011cited by this paper
• Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients

  2011cited by this paper
• Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

  2011cited by this paper
• Cancer statistics, 2011

  2011cited by this paper
• Peripheral myelin protein-22 (PMP22) modulates alpha 6 integrin expression in the human endometrium

  2011cited by this paper
• Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin

  2011cited by this paper
• Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer

  2011cited by this paper
• Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

  2011cited by this paper
• Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis

  2011cited by this paper
• Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.

  2011cited by this paper
• Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer.

  2011cited by this paper
• Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

  2011cited by this paper
• IFI16 Protein Mediates the Anti-inflammatory Actions of the Type-I Interferons through Suppression of Activation of Caspase-1 by Inflammasomes

  2011cited by this paper
• Pax8: A marker for carcinoma of Müllerian origin in serous effusions

  2011cited by this paper
• Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.

  2011cited by this paper
• Myeloid Differentiation Factor-2 Interacts with Lyn Kinase and Is Tyrosine Phosphorylated Following Lipopolysaccharide-Induced Activation of the TLR4 Signaling Pathway

  2011cited by this paper
• Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists

  2010cited by this paper
• Back to the future: Targeting molecular changes for platinum resistance reversal.

  2010cited by this paper
• Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis.

  2010cited by this paper
• Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.

  2010cited by this paper
• Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation

  2010cited by this paper
• Phospho-regulation of DDA3 function in mitosis.

  2010cited by this paper
• How the microenvironment shapes chronic lymphocytic leukemia: the cytoskeleton connection

  2010cited by this paper
• Ovarian cancer development and metastasis.

  2010cited by this paper
• Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications

  2010cited by this paper
• Microtubules and resistance to tubulin-binding agents

  2010cited by this paper
• Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.

  2010cited by this paper
• Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.

  2009cited by this paper
• Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

  2009cited by this paper
• Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

  2009cited by this paper
• Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.

  2009cited by this paper
• Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells.

  2009cited by this paper
• Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma.

  2009cited by this paper
• Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.

  2008cited by this paper
• UCA1, a non‐protein‐coding RNA up‐regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion

  2008cited by this paper
• Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.

  2008cited by this paper
• Expression and activity of taxane-metabolizing enzymes in ovarian tumors.

  2008cited by this paper
• Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCFFWD1/β‐TrCP‐mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1

  2008cited by this paper
• Claudin‐16 reduces the aggressive behavior of human breast cancer cells

  2008cited by this paper
• ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy

  2008cited by this paper
• Cancer Genes Hypermethylated in Human Embryonic Stem Cells

  2008cited by this paper
• An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

  2008cited by this paper
• TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity.

  2008cited by this paper
• Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression

  2008cited by this paper
• The plant pathogenesis related protein GLIPR-2 is highly expressed in fibrotic kidney and promotes epithelial to mesenchymal transition in vitro.

  2007cited by this paper
• MAGE-A3161–175 contains an HLA-DRβ4 restricted natural epitope poorly formed through indirect presentation by dendritic cells

  2007cited by this paper
• Endothelial lipase enhances low density lipoprotein binding and cell association in THP-1 macrophages.

  2007cited by this paper
• Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

  2007cited by this paper
• Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy.

  2007cited by this paper
• Epithelial–mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm

  2007cited by this paper
• Identification of genes with differential expression in chemoresistant epithelial ovarian cancer using high-density oligonucleotide microarrays.

  2006cited by this paper
• Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers

  2005cited by this paper
• Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase‐9 expression in a human xenograft model of prostate cancer

  2005cited by this paper
• Getting in and out of mitosis with Polo-like kinase-1

  2005cited by this paper
• Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells

  2005cited by this paper
• Adamts9 is widely expressed during mouse embryo development.

  2005cited by this paper
• Claudin proteins in human cancer: promising new targets for diagnosis and therapy.

  2005cited by this paper
• Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.

  2005cited by this paper
• Role of Voltage-gated Potassium Channels in Cancer

  2005influential reference
• A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.

  2004cited by this paper

• Boost or Bust? The Impact of Supplementation on Functional Genetic Diversity and Selective Processes in Tasmanian Devils

  2025cites this paper
• Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial–Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets

  2024cites this paper
• Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment

  2022cites this paper
• Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.

  2018cites this paper
• Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance

  2018cites this paper
• Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer

  2018cites this paper
• The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression

  2018cites this paper
• Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer

  2016cites this paper
• Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells

  2016cites this paper